Search Results 1411-1420 of 17160 for monoclonal antibody

  1. Precursor of Multiple Myeloma More Common in Blacks than Whites, Mayo Study Finds

    24, 2014 — Blacks may be twice as likely as whites to develop multiple myeloma because they are more likely to have a precursor condition known as monoclonal ...

  2. Single arm pilot trial of adaptive therapy (AT) with capecitabine for the treatment of breast cancer - Mayo Clinic

    Prior chemotherapy or use of Antibody Drug Conjugate in the Metastatic setting. Any of the following, because this study involves an agent that has known ...

  3. Detection of Infection in Arthroplasty - Mayo Clinic

    ... antibodies against microorganisms, and inflammatory markers (e.g., leukocyte esterase, CRP) in synovial fluid for the diagnosis of prosthetic joint ...

  4. Pirtobrutinib And Venetoclax With MRD Detection For Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Patients with positive hepatitis B core antibody (anti-HBc) and negative HBsAg require hepatitis B polymerase chain reaction (PCR) evaluation. Patients who ...

  5. A Study to Evaluate Myeloma-Developing Regimens Using Genomics (MyDRUG) - Mayo Clinic

    Serum monoclonal protein ≥ 0.5g by protein electrophoresis;; ≥ 200 mg of monoclonal protein in the urine on 24-hour electrophoresis;; Serum immunoglobulin ...

  6. A Study to Evaluate Effectiveness and Safety of MBG453 in Combination with Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia-2 (CMML-2) - Mayo Clinic

    History of severe hypersensitivity reaction to any ingredients of the study treatments (azacitidine or MBG453) or their excipients, or to monoclonal antibodies.

  7. Hepatitis b immune globulin (intramuscular route, intravenous route) - Side effects & uses - Mayo Clinic

    Sexual partners of persons with hepatitis B. Persons who may be exposed to the virus by means of blood, blood products, or human bites, such as health care ...

  8. Study of bb21217 in Multiple Myeloma - Mayo Clinic

    ... antibody (Note: induction with or without hematopoietic stem cell transplant and with or without maintenance therapy is considered a single line of therapy); ...

  9. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    NOTE: Patients with antibody to hepatitis B core antibody are eligible if they have no measurable viral titer. Patients who have had a hepatitis B virus ...

  10. A Study of PF-08052666/​SGN-MesoC2 in Advanced Solid Tumors - Mayo Clinic

    SGN-MesoC2 is a type of antibody-drug conjugate (ADC). ADCs are designed to stick to cancer cells and kill them. They may also stick to some normal cells ...